This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baird, A. E. Articles by McKay, W. J. Search for Related Content PubMed PubMed Citation Articles by Baird, A. E. Articles by McKay, W. J.

Stroke, Vol 25, 79-85, Copyright © 1994 by American Heart Association

ARTICLES

Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography

AE Baird, GA Donnan, MC Austin, GJ Fitt, SM Davis and WJ McKay
Department of Neurology, Austin Hospital, Victoria, Australia.

BACKGROUND AND PURPOSE--We used 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography (SPECT) to study cerebral perfusion in patients treated with streptokinase for acute ischemic stroke in an open and prospective study. Our primary aims were (1) to compare the extent of reperfusion between patients who had received thrombolytic therapy and a control group studied during the same period who were ineligible to receive such therapy and (2) to determine if, among all patients, reperfusion led to improved outcome. METHODS--Fifty- seven patients (22 treated with streptokinase) had two SPECT studies performed, the first before streptokinase administration and the second 24 hours later. RESULTS--On the first SPECT study hyperfusion was present in the middle cerebral artery or anterior cerebral artery territories in 40 patients (17 treated with streptokinase). Patients in the treatment and control groups with initial hypoperfusion on SPECT were well matched for the volume of the perfusion defect and the severity of neurological deficit. A greater number of patients who received streptokinase developed at least partial reperfusion (streptokinase, 65%; control, 52%) on the second study but not significantly so (P = .43). Similarly, the proportion of each hypoperfused region that reperfused (P = .74) and the reduction in the size of the perfusion defect (P = .06) were higher in the streptokinase group but did not reach statistical significance. When all patients were considered, those who did not reperfuse had higher mortality rates (P = .008), less neurological improvement (P = .016), and more functional disability (P < .001) than patients who had reperfusion or normal perfusion initially. CONCLUSIONS--These findings suggest that at least some reperfusion during the first 48 hours of ischemic stroke is a common natural occurrence and is of prognostic significance. The observed trend toward better reperfusion indexes among patients treated with streptokinase is encouraging, but larger controlled trials are required to answer this definitively.

This article has been cited by other articles:

				S. Ishikawa, K. Yokoyama, T. Kuroiwa, and K. Makita Evolution of cerebral ischaemia induced by thromboembolism in rats detected by early sequential MR imaging Br. J. Anaesth., September 1, 2001; 87(3): 469 - 476. [Abstract] [Full Text] [PDF]

				L. Derex, T. A. Tomsick, T. G. Brott, C. A. Lewandowski, M. R. Frankel, W. Clark, S. Starkman, J. Spilker, G. J. Udsten, J. Khoury, et al. Outcome of Stroke Patients without Angiographically Revealed Arterial Occlusion within Four Hours of Symptom Onset AJNR Am. J. Neuroradiol., April 1, 2001; 22(4): 685 - 690. [Abstract] [Full Text]

				E. E. Camargo Brain SPECT in Neurology and Psychiatry J. Nucl. Med., April 1, 2001; 42(4): 611 - 623. [Abstract] [Full Text]

				J. Berrouschot, H. Barthel, S. Hesse, W. H. Knapp, D. Schneider, and R. von Kummer Reperfusion and Metabolic Recovery of Brain Tissue and Clinical Outcome After Ischemic Stroke and Thrombolytic Therapy Stroke, July 1, 2000; 31(7): 1545 - 1551. [Abstract] [Full Text] [PDF]

				J. Berrouschot, H. Barthel, J. Koster, S. Hesse, A. Rossler, W. H. Knapp, and D. Schneider Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke : A Randomized Pilot Study Stroke, April 1, 1999; 30(4): 787 - 792. [Abstract] [Full Text] [PDF]

				P. A. Barber, S. M. Davis, B. Infeld, A. E. Baird, G. A. Donnan, D. Jolley, and M. Lichtenstein Spontaneous Reperfusion After Ischemic Stroke Is Associated With Improved Outcome Stroke, December 1, 1998; 29(12): 2522 - 2528. [Abstract] [Full Text] [PDF]

				J. C. Grotta and A. V. Alexandrov tPA-Associated Reperfusion After Acute Stroke Demonstrated by SPECT Stroke, February 1, 1998; 29(2): 429 - 432. [Abstract] [Full Text] [PDF]

				A.E. Baird, M.C. Austin, W.J. McKay, G.A. Donnan, and G.A. Donnan Sensitivity and Specificity of 99mTc-HMPAO SPECT Cerebral Perfusion Measurements During the First 48 Hours for the Localization of Cerebral Infarction Stroke, May 1, 1997; 28(5): 976 - 980. [Abstract] [Full Text]

				B. Infeld, S. M. Davis, G. A. Donnan, M. Lichtenstein, A. E. Baird, D. Binns, P. J. Mitchell, and J. L. Hopper Streptokinase Increases Luxury Perfusion After Stroke Stroke, September 1, 1996; 27(9): 1524 - 1529. [Abstract] [Full Text]

				B. Infeld, S. M. Davis, M. Lichtenstein, P. J. Mitchell, and J. L. Hopper Crossed Cerebellar Diaschisis and Brain Recovery After Stroke Stroke, January 1, 1995; 26(1): 90 - 95. [Abstract] [Full Text]